UK markets closed

Allscripts Healthcare Solutions, Inc. (MDRX)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
7.90+0.10 (+1.28%)
As of 01:43PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close7.80
Open7.65
Bid0.00 x 2900
Ask0.00 x 1000
Day's range7.50 - 8.00
52-week range5.01 - 14.09
Volume224,691
Avg. volume4,833,398
Market cap863.154M
Beta (5Y monthly)0.62
PE ratio (TTM)9.19
EPS (TTM)0.86
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date07 Oct 2008
1y target est14.60
  • Business Wire

    Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

    CHICAGO, March 14, 2024--Veradigm Inc. (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions announced today that Dr. Yin Ho, Veradigm Interim Chief Executive Officer and board member, Lee Westerfield, Interim Chief Financial Officer, and Will Manidis Co-Founder of ScienceIO will participate in a fireside chat at the KeyBanc Capital Markets Life Science & MedTech Investor Forum on Tuesday, March 19th, 2024 at 12:00 PM EDT.

  • Business Wire

    Veradigm Announces Initial Financial Guidance for Fiscal 2024

    CHICAGO, March 13, 2024--Veradigm Inc. (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today it has reaffirmed the estimated, unaudited ranges for fiscal 2023 of GAAP Revenue, Adjusted EBITDA, and Non-GAAP diluted earnings per share that it provided on January 10, 2024, in the Company’s Form 8-K filed on January 10, 2024, and initially reaffirmed on February 27, 2024.

  • Business Wire

    Veradigm to Participate in Barclays 26th Annual Global Healthcare Conference

    CHICAGO, March 04, 2024--Veradigm Inc. (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions announced today that Dr. Yin Ho, Veradigm interim Chief Executive Officer and board member, Lee Westerfield, interim Chief Financial Officer, and Will Manidis, Senior Vice President and the former CEO of ScienceIO, will participate in a fireside chat and investor Q&A, as well as meet with investor attendees during the Barclays 26th Annual Global Healthcare Conference on Wednesda